These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Safety of ceftriaxone in paediatrics: a systematic review. Zeng L; Wang C; Jiang M; Chen K; Zhong H; Chen Z; Huang L; Li H; Zhang L; Choonara I Arch Dis Child; 2020 Oct; 105(10):981-985. PubMed ID: 32144089 [TBL] [Abstract][Full Text] [Related]
43. Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study. Bor O; Dinleyici EC; Kebapci M; Aydogdu SD Pediatr Int; 2004 Jun; 46(3):322-4. PubMed ID: 15151550 [TBL] [Abstract][Full Text] [Related]
44. Retrograde intrarenal surgery for the treatment of renal stones in children: factors influencing stone clearance and complications. Azili MN; Ozcan F; Tiryaki T J Pediatr Surg; 2014 Jul; 49(7):1161-5. PubMed ID: 24952809 [TBL] [Abstract][Full Text] [Related]
45. [Sodium excretion in children with lithogenic disorders]. Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402 [TBL] [Abstract][Full Text] [Related]
46. Evaluation and medical management of kidney stones in children. Tasian GE; Copelovitch L J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469 [TBL] [Abstract][Full Text] [Related]
47. [Renal staghorn calculi in small children - presentation of two cases]. Krzemień G; Szmigielska A; Jankowska-Dziadak K; Pańczyk-Tomaszewska M Dev Period Med; 2016; 20(1):23-6. PubMed ID: 27416622 [TBL] [Abstract][Full Text] [Related]
48. Possible function of urinary pH and citrate on the ceftriaxone-induced nephrolithiasis. Cong X; Gu X; Sun X; Ning B; Shen L Urology; 2014 Jan; 83(1):63-7. PubMed ID: 24231212 [TBL] [Abstract][Full Text] [Related]
49. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature. Bickford CL; Spencer AP Pharmacotherapy; 2005 Oct; 25(10):1389-95. PubMed ID: 16185184 [TBL] [Abstract][Full Text] [Related]
50. Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction. Imafuku A; Sawa N; Sekine A; Kawada M; Hiramatsu R; Yamanouchi M; Hasegawa E; Hayami N; Hoshino J; Ubara Y; Takaichi K Clin Exp Nephrol; 2018 Jun; 22(3):613-619. PubMed ID: 29027036 [TBL] [Abstract][Full Text] [Related]
51. Acute kidney injury caused by ceftriaxone-induced urolithiasis in children: a single-institutional experience in diagnosis, treatment and follow-up. Shen X; Liu W; Fang X; Jia J; Lin H; Xu M; Geng H Int Urol Nephrol; 2014 Oct; 46(10):1909-14. PubMed ID: 24879561 [TBL] [Abstract][Full Text] [Related]
52. Ceftriaxone and acute renal failure in children. Li N; Zhou X; Yuan J; Chen G; Jiang H; Zhang W Pediatrics; 2014 Apr; 133(4):e917-22. PubMed ID: 24664092 [TBL] [Abstract][Full Text] [Related]
54. Urinary metabolic evaluations in normal and stone forming children. DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651 [TBL] [Abstract][Full Text] [Related]
55. Infant nephrolithiasis and nephrocalcinosis: Natural history and predictors of surgical intervention. Andrioli V; Highmore K; Leonard MP; Guerra LA; Tang K; Vethamuthu J; Meyers V; Sullivan KJ; Keays MA J Pediatr Urol; 2017 Aug; 13(4):355.e1-355.e6. PubMed ID: 28729176 [TBL] [Abstract][Full Text] [Related]
56. Progression of asymptomatic nephrolithiasis in children: How often should patients receive follow-up ultrasound imaging? Jayman J; Gibbs H; Mathias R; Epelman M; Ellsworth P J Pediatr Urol; 2022 Feb; 18(1):25.e1-25.e8. PubMed ID: 34756785 [TBL] [Abstract][Full Text] [Related]
57. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough? Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204 [TBL] [Abstract][Full Text] [Related]